Doctronic navigation menu Log In
Doctronic navigation menu
Contents
  • Understanding APS Risk Factors
  • Lifestyle and Environmental Influences
  • Medical History and APS

Are You at Risk for Antiphospholipid Syndrome?

Are You at Risk for Antiphospholipid Syndrome?

Why It Matters

Identifying risk factors for Antiphospholipid Syndrome (APS) can help you take proactive steps towards prevention and management.
Contents
  • Understanding APS Risk Factors
  • Lifestyle and Environmental Influences
  • Medical History and APS

Understanding APS Risk Factors

APS can be influenced by various risk factors, including underlying autoimmune diseases like lupus. Genetic predispositions may also play a role, increasing the likelihood of developing APS. Keeping an eye on these risk factors can aid in early diagnosis and management of the condition.

Lifestyle and Environmental Influences

Certain lifestyle choices and environmental factors may exacerbate APS risk. Smoking, obesity, and prolonged immobility can increase the likelihood of blood clot formation. Awareness of these factors can lead to lifestyle changes that may reduce the risk of APS-related complications.
Antiphospholipid Syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies, increasing the risk of blood clots. It is influenced by genetic predispositions and lifestyle factors.

Medical History and APS

A history of blood clots, miscarriages, or autoimmune conditions can indicate a higher risk for APS. Regular monitoring and communication with healthcare providers are essential for those with such histories. Early intervention can help manage symptoms and prevent complications.

FAQs

What are APS risk factors?

Risk factors include autoimmune diseases and genetics.

Can lifestyle affect APS risk?

Yes, smoking and obesity can increase risk.

Does medical history impact APS risk?

Yes, a history of clots or miscarriages increases risk.

The Bottom Line

Knowing your risk factors can empower you to take control of your health.
Discuss your APS risk factors with Doctronic to stay informed and proactive!
Additional References
  1. Cervera R, Serrano R, Pons-Estel GJ, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2015; 74:1011.
  2. Schmidt-Tanguy A, Voswinkel J, Henrion D, et al. Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients. J Thromb Haemost 2013; 11:1927.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.